Clinical Trials Browser

INDUSTRY × tomivosertib × Genitourinary × Clear all

NCT03690141 2024-06-21

An Open-label Study of the Effect of Tomivosertib (eFT508) in Patients With Advanced Castrate-resistant Prostate Cancer

Phase 2 Terminated

16 enrolled 9 charts

Prostatic Neoplasms